Method for expressing and purifying protein by using csq-tag
US-2024209046-A1 · Jun 27, 2024 · US
Epidermal growth factor [EGF], i.e. urogastrone
Epidermal growth factor [EGF], i.e. urogastrone · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K14/485 |
| Official title | Epidermal growth factor [EGF], i.e. urogastrone |
| Display label | Epidermal growth factor [EGF], i.e. urogastrone |
| Total patents | 239 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is stable.
| Year | Patents |
|---|---|
| 2015 | 33 |
| 2016 | 28 |
| 2017 | 29 |
| 2018 | 24 |
| 2019 | 23 |
| 2020 | 19 |
| 2021 | 16 |
| 2022 | 13 |
| 2023 | 20 |
| 2024 | 14 |
| 2025 | 15 |
| 2026 | 5 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Bi-Specific Fusion Proteins
US-2024101713-A1 · Mar 28, 2024 · US
Multivalent heteromultimer scaffold design and constructs
US-9499605-B2 · Nov 22, 2016 · US
Binding-triggered transcriptional switches and methods of use thereof
US-2016264665-A1 · Sep 15, 2016 · US
Polynucleotides Encoding Low Density Lipoprotein Receptor
US-2016244501-A1 · Aug 25, 2016 · US
Multivalent heteromultimer scaffold design and constructs
US-2016207979-A1 · Jul 21, 2016 · US
Multivalent heteromultimer scaffold design and constructs
US-9388231-B2 · Jul 12, 2016 · US
Bi-Specific Fusion Proteins
US-2016168269-A1 · Jun 16, 2016 · US
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US-2016158385-A1 · Jun 9, 2016 · US
Modified polynucleotides for the production of proteins
US-2016151516-A1 · Jun 2, 2016 · US
Means and methods for modulating NOTCH3 protein expression and/or the coding region of NOTCH3; compositions and use thereof in the treatment of CADASIL
US-9353169-B2 · May 31, 2016 · US
Dnazyme for silencing the expression of egfr
US-2016145625-A1 · May 26, 2016 · US
Methods and compositions for heptameric targeting ligands
US-9340616-B2 · May 17, 2016 · US
Cosmetic composition for improving skin conditions comprising fusion protein
US-9321821-B2 · Apr 26, 2016 · US
Gla domains as targeting agents
US-2016106806-A1 · Apr 21, 2016 · US
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US-9303079-B2 · Apr 5, 2016 · US
Modified polynucleotides encoding apoptosis inducing factor 1
US-9301993-B2 · Apr 5, 2016 · US
Target-specific non-antibody protein and method for preparing the same
US-9296802-B2 · Mar 29, 2016 · US
Modified polynucleotides for the production of biologics and proteins associated with human disease
US-2016075733-A1 · Mar 17, 2016 · US
Vault Complexes for Facilitating Biomolecule Delivery
US-2016068576-A1 · Mar 10, 2016 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K14/485?
- CPC C07K14/485 is the Cooperative Patent Classification code for “Epidermal growth factor [EGF], i.e. urogastrone.”
- How many patents are filed under CPC C07K14/485 (Epidermal growth factor [EGF], i.e. urogastrone)?
- Our database includes 239 publications tagged with this CPC code.
- Is patent activity under CPC C07K14/485 growing?
- Publication counts under this code: 14 in 2024 vs 15 in 2025 (latest complete years).